Search Results - "Carballo, Erica V"

Surgical outcomes of adnexal masses classified by IOTA ultrasound simple rules by Carballo, Erica V., Maturen, Katherine E., Li, Zhanhai, Patel-Lippmann, Krupa K., Wasnik, Ashish P., Sadowski, Elizabeth A., Barroilhet, Lisa M.

“…IOTA (International Ovarian Tumor Analysis) Simple Rules classifies adnexal masses as benign, malignant, or indeterminate based on sonographic features. We…”
Get full text

Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease status by Penn, Courtney A., Carballo, Erica V., Walsh, Christine S., Zivanovic, Oliver, Kim, Kenneth H.

“…•Evaluation of cost-effectiveness of HIPEC at primary cytoreduction surgery (PCS) until results of OVHIPEC-2 are available.•Total costs for PCS were $32,169…”
Get full text

Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib by Carballo, Erica V., Pham, Tra V., Turashvili, Gulisa, Hanley, Krisztina, Starbuck, Kristen D., Meisel, Jane L.

“…•Inflammatory myofibroblastic tumors can mimic leiomyosarcoma histologically.•Highlights the role of molecular testing in the diagnosis and management of…”
Get full text

Benign ovarian thecoma with markedly elevated serum inhibin B levels mimicking adult granulosa cell tumor by Carballo, Erica V., Gyorfi, Kaley M., Stanic, Aleksandar K., Weisman, Paul, Flynn, Christopher G., Kushner, David M.

“…•A rare case of markedly elevated inhibin B associated with an ovarian thecoma.•Inhibin B lacks specificity as a tumor marker for adult granulosa cell tumor.•A…”
Get full text

Trends in estimated PARP inhibitor eligibility and benefit among US epithelial ovarian cancer patients by Carballo, Erica V., Kim, Kenneth H., Penn, Courtney A.

“…To estimate the annual percentage of patients with epithelial ovarian cancer (EOC) who could be eligible for and benefit from PARP inhibitor therapy amidst…”
Get full text

Uterine Cervical Sarcoma With a Novel RET-SPECC1L Fusion in an Adult: A Case Which Expands the Homology Between RET-rearranged and NTRK-rearranged Tumors by Weisman, Paul S., Altinok, Morgan, Carballo, Erica V., Kushner, David M., Kram, Jessica J.F., Ladanyi, Marc, Chiang, Sarah, Buehler, Darya, Dickson Michelson, Elizabeth L.

Get full text

1 Examining the immune tumor microenvironment of endometrial cancer patients treated with pembrolizumab plus lenvatinib by Carballo, Erica V., Wu, Sharon, Angara, Kartik, Penn, Courtney A., Herzog, Thomas J., Thaker, Premal, Starbuck, Kristen

“…Our aim is to examine the immune microenvironment of endometrial cancer (EMCA) patients treated with pembrolizumab plus lenvatinib (P+L) that could contribute…”
Get full text

31 Trends in estimated percent of patients with epithelial ovarian cancer eligible for and responding to PARP inhibitors over time by Carballo, Erica V., Kamdar, Neil, Penn, Courtney A.

“…We seek to estimate the annual percentage of patients with advanced-stage epithelial ovarian cancer in the United States who are eligible for and will derive…”
Get full text

Benign ovarian thecoma with markedly elevated serum inhibin B levels mimicking adult granulosa cell tumor by Carballo, Erica V, Gyorfi, Kaley M, Stanic, Aleksandar K, Weisman, Paul, Flynn, Christopher G, Kushner, David M

“…INTRODUCTIONElevated serum inhibin B is a classic marker of adult granulosa cell tumors. Here we discuss an extremely rare and informative case of elevated…”
Get full text

Uterine Cervical Sarcoma With a Novel RET-SPECC1L Fusion in an Adult: A Case Which Expands the Homology Between RET-rearranged and NTRK-rearranged Tumors by Weisman, Paul S, Altinok, Morgan, Carballo, Erica V, Kushner, David M, Kram, Jessica J F, Ladanyi, Marc, Chiang, Sarah, Buehler, Darya, Dickson Michelson, Elizabeth L

Get full text